These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16003667)

  • 61. National trends in the provision of smoking cessation aids within the Veterans Health Administration.
    Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM
    Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of age on initiation of mental health treatment after positive PTSD screens among Veterans Affairs primary care patients.
    Lu MW; Carlson KF; Duckart JP; Dobscha SK
    Gen Hosp Psychiatry; 2012; 34(6):654-9. PubMed ID: 22898446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessing the accuracy of computerized medication histories.
    Kaboli PJ; McClimon BJ; Hoth AB; Barnett MJ
    Am J Manag Care; 2004 Nov; 10(11 Pt 2):872-7. PubMed ID: 15609741
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
    Krause I; Kern S; Horntrich A; Ziemssen T
    Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multiple sclerosis-related fatigue.
    MacAllister WS; Krupp LB
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):483-502. PubMed ID: 15893683
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brief report: beta-blocker use among veterans with systolic heart failure.
    Sinha S; Goldstein M; Penrod J; Hochman T; Kamran M; Tenner C; Cohen G; Schwartz MD
    J Gen Intern Med; 2006 Dec; 21(12):1306-9. PubMed ID: 17105526
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of prescription size on acquisition of maintenance medications.
    Steiner JF; Robbins LJ; Roth SC; Hammond WS
    J Gen Intern Med; 1993 Jun; 8(6):306-10. PubMed ID: 8320574
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.
    McKay KA; Marrie RA; Fisk JD; Patten SB; Tremlett H
    Neuroepidemiology; 2018; 51(1-2):1-10. PubMed ID: 29763935
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.
    Braley TJ; Chervin RD
    Sleep; 2010 Aug; 33(8):1061-7. PubMed ID: 20815187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patients.
    Carnero Contentti E; Pettinicchi JP; López PA; Alonso R; Garcea O; Balbuena ME; Bortoluzzi C; Silva E; Cabrera M; Curbelo MC; Hryb JP; Di Pace JL; Perassolo M; Ianardi S; Mainella C; Mellinger S; Migliacci L; Pagani Cassara F; Sinay V; Carra A; Qüesta Laudani M; Ruiz Romagnoli E; Liwacki S; Piedrabuena R; Tizio S; Tkachuk V
    Mult Scler Relat Disord; 2019 Aug; 33():88-93. PubMed ID: 31174044
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demographic and Clinical Factors Are Associated With Frequent Short-Notice Cancellations in Veterans With Multiple Sclerosis on Disease Modifying Therapies.
    Gromisch ES; Turner AP; Leipertz SL; Beauvais J; Haselkorn JK
    Arch Phys Med Rehabil; 2022 May; 103(5):915-920.e1. PubMed ID: 34695387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High dose thiamine improves fatigue in multiple sclerosis.
    Costantini A; Nappo A; Pala MI; Zappone A
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23861280
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
    Morrison JD; Stuifbergen AK
    J Neurosci Nurs; 2016 Jun; 48(3):143-50. PubMed ID: 27136408
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
    Hadjimichael O; Vollmer T; Oleen-Burkey M;
    Health Qual Life Outcomes; 2008 Nov; 6():100. PubMed ID: 19014588
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictors of prescriptions for management of fatigue among veterans with multiple sclerosis.
    Hatzakis M; Turner AP; Williams RM; Bowen JD; Rodriquez AA; Haselkorn JK
    Arch Phys Med Rehabil; 2005 Jul; 86(7):1376-80. PubMed ID: 16003667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fatigue in multiple sclerosis: an overview of assessment and pharmacologic treatment.
    Dunmore FR
    Adv NPs PAs; 2013 Apr; 4(4):23-5, 32. PubMed ID: 23599993
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans.
    Vollmer TL; Hadjimichael O; Preiningerova J; Ni W; Buenconsejo J
    J Rehabil Res Dev; 2002; 39(2):163-74. PubMed ID: 12051461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.